Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
Revenue minus cost of goods sold
| Period | Value | Change |
|---|---|---|
| 2024 | $9.16M | +10.8% |
| 2023 | $8.27M | -40.8% |
| 2022 | $13.97M | +465.8% |
| 2021 | $2.47M | +536.6% |
| 2020 | $388000.00 | -63.6% |
| 2019 | $1.07M | -4.3% |
| 2018 | $1.11M | -31.4% |
| 2017 | $1.62M | -14.3% |
| 2016 | $1.89M | +32.7% |
| 2015 | $1.43M | - |